Euro vs US Dollar

Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.

Registrieren

EDIT Editas Medicine Inc

5,65

-0,02 (-0,35%)

Zuletzt aktualisiert: 21:43:35

Verzögert um 15 Minuten

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]

null

Editas Medicine (NASDAQ:EDIT)
Historical Stock Chart
Von Apr 2024 bis Mai 2024

Click Here for more Editas Medicine Charts.

Editas Medicine (NASDAQ:EDIT)
Historical Stock Chart
Von Mai 2023 bis Mai 2024

Click Here for more Editas Medicine Charts.

News Editas Medicine Inc

Editas Medicine Announces First Quarter 2024 Results Conference Call and Upcoming Investor Events
Donnerstag 2 Mai 2024 (4 Tage vor) • GlobeNewswire Inc.

Editas Medicine and Bristol Myers Squibb Extend Alpha-Beta T Cell Collaboration
Mittwoch 1 Mai 2024 (5 Tage vor) • GlobeNewswire Inc.

Editas Medicine to Present Pre-clinical Data Demonstrating Progression of in vivo Medicines Pipeline at the American Society of Gene and Cell Therapy Annual Meeting
Montag 22 April 2024 (2 Wochen vor) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Mittwoch 6 März 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Mittwoch 6 März 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Mittwoch 6 März 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Mittwoch 6 März 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Montag 4 März 2024 (2 Monate vor) • Edgar (US Regulatory)

Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers
Mittwoch 28 Februar 2024 (2 Monate vor) • Edgar (US Regulatory)

Form S-8 - Securities to be offered to employees in employee benefit plans
Mittwoch 28 Februar 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Mittwoch 28 Februar 2024 (2 Monate vor) • Edgar (US Regulatory)

Editas Medicine Announces Fourth Quarter and Full Year 2023 Results and Business Updates
Mittwoch 28 Februar 2024 (2 Monate vor) • GlobeNewswire Inc.

Weitere Editas Medicine Inc News-Artikel

Euro vs US Dollar

BNP Paribas (QX)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen